Clinical Trials · NCT06973304

A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome

Name: A Study of Teduglutide in Chinese Adults With Short Bowel Syndrome
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 3Teduglutide

Phase: Phase 3
Recruitment status: Recruiting
Sponsor: Takeda
Enrollment: 13
Start date: Jun 2025
Locations: 4 sites, China
Primary endpoint: Percentage of Participants Who Achieved At Least 20 Percent (%) Reduction From Baseline in Weekly Parenteral Support (PS) Volume at Week 20 and Maintained Through Week 24

View Teduglutide compound reference